Viewing Study NCT01851603


Ignite Creation Date: 2025-12-24 @ 7:13 PM
Ignite Modification Date: 2025-12-25 @ 4:48 PM
Study NCT ID: NCT01851603
Status: TERMINATED
Last Update Posted: 2016-12-30
First Post: 2013-05-06
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Phase I Study to Evaluate the Safety and Pharmacokinetics of Oral Doses of Anvylic-3288 in Healthy Subjects
Sponsor: University of Colorado, Denver
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module